CLOSTRIDIUM DIFFICILE INFECTION - 30-MONTH RECURRENCE RATE

  • Georgiana Alexandra LACATUSU “Sf. Parascheva” Clinical Hospital of Infectious Diseases Iasi, Romania
  • Ioana Florina MIHAI “Sf. Parascheva” Clinical Hospital of Infectious Diseases Iasi, Romania

Abstract

Aim: To evaluate the recurrence rate of Clostridium difficile  infection (CDI) in the patients admitted to the Iasi “Sf. Parascheva” Infectious Diseases Hospital. Material and methods: Observational retrospective study of the patients admitted between January 1st, 2017 and June 30th, 2019. Results: Of the total of 736 patients diagnosed with CDI and admitted to our hospital  240 were included in this study. According to the number of CDI recurrences, 63.81 % of the patients experienced a first recurrence of CDI, over 20% a second recurrence, and the remaining patients a third to sixth recurrence. Conclusions: CDI is still a serious problem and a major burden on both the healthcare system and the patient. The causes of recurrent CDI are unclear.

Author Biography

Ioana Florina MIHAI, “Sf. Parascheva” Clinical Hospital of Infectious Diseases Iasi, Romania

“Grigore T. Popa” University of Medicine and Pharmacy Iasi
Faculty of Medicine
Department of Medical Specialties (II)

References

1. Khanna S, Pardi DS. The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings. Expert Rev Gastroenterol Hepatol 2010; 4: 409-416.
2. Maharshak N, Barzilay I, Zinger H, Hod K, Dotan I. Clostridium difficile infection in hospitalized patients with inflammatory bowel disease: Prevalence, risk factors, and prognosis. Medicine (Baltimore) 2018; 97(5): e9772.
3. Evans CT, Safdar N. Current trends in the epidemiology and outcomes of Clostridium difficile infec-tion. Clin Infect Dis 2015; 60(Suppl 2): S66-71.
4. Lessa FC, Mu Y, Bamberg WM, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015; 372(9): 825-834.
5. Shields K, Araujo-Castillo RV, Theethira TG, Alonso CD, Kelly CP. Recurrent Clostridium difficile infection: from colonization to cure. Anaerobe 2015; 34: 59-73.
6. O’Donoghue C, Kyne L. Update on Clostridium difficile infection. Curr Opin Gastroenterol 2011; 27: 38-47.
7. Kwok CS, Arthur AK, Anibueze CI, et al. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Am J Gastroenterol 2012; 107: 1011-1019.
8. Loo VG, Bourgault AM, Poirier L, et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med 2011; 365: 1693-703.
9. Meyer AM, Ramzan NN, Loftus EV Jr, et al. The diagnostic yield of stool pathogen studies during relapses of inflammatory bowel disease. J Clin Gastroenterol 2004; 38: 772-775
10. Hopkins RJ, Wilson RB. Treatment of recurrent Clostridium difficile colitis: a narrative review, Gastroenterol Rep 2018; 6(1): 21-28.
11. Iordan IF, Manciuc C. Double Problem-Clostridium difficile and Diabetes. Jo Pharmacy Pharmaco 2018; 6: 170-174.
12. Cole SA., Stahl TJ. Persistent and Recurrent Clostridium difficile Colitis. Clinics in colon and rectal surgery 2015; 28(2): 065-069.
13. Peng Z, Ling L, Stratton CW, Li C, Polage CR, Wu B, Tang YW. Emerg Microbes Infect 2018; 7(1): 15.
14. Manciuc C, Filip-Ciubotaru F, Badescu A, Duceac LD, Largu AM. The patient-doctor-psychologist triangle in a case of severe immunosuppression in the HIV infection. Rev Med Chir Soc Med Nat Iasi 2016; 120(1): 119-123.
15. Manciuc C, Dorobat C, Danaila C, Largu MA. Lymphoma in an HIV-positive patient. Rev Med Chir Soc Med Nat Iasi 2015; 119(1): 97-100.
16. Dorobăț CM, Luca CM, Miftode E, Manciuc C, Leca D, Hurmuzache M. Boli infecțioase diagnostic și tratament Iași: Editura “Gr. T. Popa” UMF, 2012.
17. Deshpande A, Pasupuleti V, Thota P, Pant C, Rolston DD, Hernandez AV, Donskey CJ, Fraser TG Community-associated Clostridium difficile infection and antibiotics: a meta-analysis Infect Control Hosp Epidemiol 2015; 36(4): 452-460.
18. Chitnis AS, Holzbauer SM, Belflower RM, et al. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011. JAMA Intern Med 2013; 173: 1359-1367
19. Mitchell BG, Gardner A. Prolongation of length of stay and Clostridium difficile infection: a review of the methods used to examine length of stay due to healthcare associated infections Antimicrob Resist Infect Control 2012; 1: 14.
20. Iordan IF, Adavidoaiei AM, Savu IA, Nastase E, Filip-Ciubotaru F, Manciuc C. Increasing incidence of recurrent Clostridium difficile infection Rev Med Chir Soc Med Nat Iasi 2017; 121(3): 505-509.
Published
2019-12-29
Issue
Vol 123 No 4 (2019): The Medical-Surgical Journal
Section
INTERNAL MEDICINE - PEDIATRICS

COPYRIGHT 
Once an article is accepted for publication, MSJ requests a transfer of copyrights for published articles.

COPYRIGHT TRANSFER FORM FOR 

REVISTA MEDICO-CHIRURGICALĂ A SOCIETĂȚII DE MEDICI ȘI NATURALIȘTI DIN IAȘI /

THE MEDICAL-SURGICAL JOURNAL OF THE SOCIETY OF PHYSICIANS AND NATURALISTS FROM IASI

We, the undersigned authors of the manuscript entitled

_____________________________________________________________________________________

_____________________________________________________________________________________

warrant that this manuscript, which is submitted for publication in the REVISTA MEDICO-CHIRURGICALĂ, has not been published and it is not under consideration for publication in another journal.

  1. we give the consent for publication in the REVISTA MEDICO-CHIRURGICALĂ, in printed and electronic format and we transfer unconditioned and complete the copyright of this manuscript to the REVISTA MEDICO-CHIRURGICALĂ, in the event of its acceptance.
  2. the manuscript does not break the intellectual property rights of any other person.
  3. we have read the submitted version of the manuscript and we are fully responsible for the content.

Names and signatures of authors / copyright owners (the following sequence is the authorship of the article):

  1. ______________________________/_________________________
  2. ______________________________/_________________________
  3. ______________________________/_________________________

N.B.  All the authors must sign this form